HomeNewsBusinessCadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher

Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher

Net Sales are expected to decrease by 0.2 percent Y-o-Y (up 0.1 percent Q-o-Q) to Rs 3,788.1 crore, according to Prabhudas Lilladher.

January 13, 2022 / 15:09 IST
Story continues below Advertisement
Pharma (Representational image: Shutterstock)
Pharma (Representational image: Shutterstock)

Prabhudas Lilladher has come out with its third quarter (October-December’ 21) earnings estimates for the Pharma sector. The brokerage house expects Cadila Healthcare to report net profit at Rs 544 crore up 3.2% year-on-year (up 7.5% quarter-on-quarter).

Net Sales are expected to decrease by 0.2 percent Y-o-Y (up 0.1 percent Q-o-Q) to Rs 3,788.1 crore, according to Prabhudas Lilladher.

Story continues below Advertisement

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 3.7 percent Y-o-Y (down 2.8 percent Q-o-Q) to Rs 836.4 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.